 |
|
|
| |
Virological failure rate and emergent resistance in real-world studies evaluating long-acting cabotegravir and rilpivirine in people with baseline viral suppression
|
| |
| |
Glasgow 2024 Nov 10-13
Dr Melanie Smuk1, Ms Alexa Elias1, Dr Kyle Ring1 2, Prof Chloe Orkin1 2
1SHARE Collaborative, Blizard Institute, Queen Mary University of London, London, UK, 2Barts Health NHS Trust, London, UK
|
| |
|
|
|
|
|
